ATRA’s statement on passage of Amendment 1 to Illinois House Bill 3360
In re Lipitor
(4th Circuit, filed July 8, 2017): Arguing that under Daubert, reliable science does not involve result-seeking statistical hacking nor does it presume that effects observable at one dose apply to all doses. Also arguing that MDL courts have the power to dismiss cases when plaintiffs fail to come forward with evidence on specific causation after being given a chance to do so.
On June 12, 2018, the Court ruled in favor of ATRA’s position.
ATRA’s statement on Amendment 1 to Illinois House Bill 3360
ATRA President Tiger Joyce released the following statement in response to the unprecedented attack on the U.S. Capitol building on January 6:
ATRA voices its disappointment as Congress fails to include liability protections in its latest COVID-19 relief package.
ATRA President Tiger Joyce writes in this op-ed about a growing trend of state courts bucking SCOTUS precedent when it comes to personal jurisdiction.
Activism in AG’s office, Supreme Court’s acceptance of lawsuit funding and loose venue rules to blame